Wireless Transcutaneous Energy Transfer (TET) System for Powering a LVAD is Successful FineHeart tests powers ICOMS Heart Pump and is a major step prior to first in human trials The FineHeart Transcutaneous Energy Transfer (TET) System for the ICOMS cardiac assist device. 1. The ICOMS heart pump. 2. The implanted TET transfer pad. 3. The external energy transfer pad. January 13, 2021 — FineHeart, a preclinical-stage medical device company developing a novel left ventricular assist device (LVAD), successfully completed a seven-day study of its Transcutaneous Energy Transfer (TET) System for recharging the ICOMS implantable battery without any cords or drivelines through the skin. FineHeart's TET is a system with no percutaneous driveline that transfers energy through the skin to charge the ICOMS pump battery. TET is rapidly implantable (less than 15 mins) and will give patients autonomy without the need for tethering cables from the device leading outside of the body. The elimination of the external driveline will reduce infections and complications that cause high rates of mortality with current circulatory support systems used in severe heart failure patients.